melanoma



dynaCERT Inc.
Latest Comments
image_pdfimage_print

MedX Health distribution partnership with VidaCeuticals sets the groundwork for a broader market roll-out in Canada

When we last looked at MedX Health Corp. (TSXV: MDX) we talked about how the heavy lifting had been done, […]


World class skin cancer diagnostic technology prepares to treat the world.

Have you ever tried to get a dermatology appointment? I don’t know about anywhere else in the world but in […]


A more accurate assessment on skin cancer is the way MedX plans to save the planet

No one should ever die of skin cancer. Wow – doesn’t that just wake you up a little bit? The […]


MedX Health explains why no one should ever die from skin cancer

InvestorIntel’s Tracy Weslosky talks with MedX Health Corp.‘s (TSXV: MDX) Executive Chairman & CEO Robert Von Der Porten and Mike […]


Mike Druhan on bringing MedX’s skin cancer detection technology to Brazil

In an InvestorIntel interview during PDAC last week, Tracy Weslosky secures an interview update with Vice President of Corporate Development Mike Druhan […]


Druhan on MedX’s skin cancer diagnosis technology getting closer to being launched in Brazil

“MedX solves a really unique problem and that is access to a dermatologist. In Canada, there are 565 dermatologists serving 37 […]


How MedX technology can have your potential skin cancer diagnosed in 72 hours

“MedX is a company that has a visual technology that allows image capture not only on top of the skin […]


Mike Druhan on the competitive advantages of MedX’s skin cancer diagnosis technology

“We have launched a new product called DermSecureTM…We can take a picture on the top of the skin of a […]